Antimicrobial resistance and COVID-19: Intersections and implications

  title={Antimicrobial resistance and COVID-19: Intersections and implications},
  author={Gwenan M. Knight and Rebecca E. Glover and Christopher Finn McQuaid and Ioana Diana Olaru and Karin Gallandat and Quentin J. Leclerc and Naomi M. Fuller and Samuel J Willcocks and Rumina Hasan and Esther van Kleef and Clare I. R. Chandler},
Before the coronavirus 2019 (COVID-19) pandemic began, antimicrobial resistance (AMR) was among the top priorities for global public health. Already a complex challenge, AMR now needs to be addressed in a changing healthcare landscape. Here, we analyse how changes due to COVID-19 in terms of antimicrobial usage, infection prevention, and health systems affect the emergence, transmission, and burden of AMR. Increased hand hygiene, decreased international travel, and decreased elective hospital… 

Figures from this paper

Antimicrobial resistance and the COVID-19 pandemic

The COVID-19 pandemic has highlighted the vulnerability of health-care systems in controlling infectious disease threats and increased awareness of the importance of planning for emerging infections and maintaining robust infection control, and generated opportunities that should be seized to harness positive effects on the management of antimicrobial resistance.

Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance

Abstract Antibiotic use in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients during the COVID-19 pandemic has exceeded the incidence of bacterial coinfections and secondary

Les misérables: a Parallel Between Antimicrobial Resistance and COVID-19 in Underdeveloped and Developing Countries

The data compiled in this study underscore the importance of epidemiological surveillance of hospital isolates to provide new strategies for preventing and controlling infections caused by multidrug-resistant bacteria.

Beyond the Pandemic: The Value of Antimicrobial Stewardship

The importance and role of AMS and global coordination of efforts against AMR cannot be overemphasized with respect to implementation of new stewardship programs and strengthening of existing ones; improving access to diagnostics and laboratory equipment; development and dissemination of evidence-based guidelines for appropriate antimicrobial use.

Antimicrobial Resistance in the COVID-19 Landscape: Is There an Opportunity for Anti-Infective Antibodies and Antimicrobial Peptides?

Nature-derived anti-infective agents, such as antibodies and antimicrobial peptides (AMPs), are very promising in the fight against infectious diseases, because they are less likely to develop resistance, even though further investigation is still required.

Inappropriate Antibiotic Use in Zimbabwe in the COVID-19 Era: A Perfect Recipe for Antimicrobial Resistance

The global COVID-19 pandemic has resulted in an upsurge in antimicrobial use, and is particularly related to the empirical treatment of SARS-CoV-2 and suspected coinfections with antimicrobials and the limited quality of diagnostics to differentiate viral and bacterial pneumonia.

The Impact of the COVID-19 Pandemic on Antibiotic Prescribing Trends in Outpatient Care: A Nationwide, Quasi-Experimental Approach

A significant, immediate decrease in the overall antibiotic prescribing trends was noticed in the context of outpatient care in Portugal, followed by a statistically non-significant fall over the long term, revealing an important disruption in antibiotics prescribing caused by the current public health emergency.

Assessment of antibiotic resistance changes during the Covid-19 pandemic in northeast of Iran during 2020–2022: an epidemiological study

All 4 species evaluated in this study, have shown rising AMR rates during the first year of the pandemic in the northeast of Iran, and E. coli, P. pneumoniae, and A. baumannii strains in Northern Iran have a higher level of antibiotic resistance than what was measured in similar studies conducted before thePandemic.

impact of the COVID-19 pandemic on antimicrobial resistance at Dr. Soetomo Academic Hospital of Surabaya

Comparing microorganism profile data, prevalence of multidrug-resistant microorganisms, and susceptibility patterns in patients treated at Dr. Soetomo Surabaya Hospital before and during the coronavirus disease-2019 pandemic finds significant decrease in the prevalence of E. coli and S. aureus and significant increase in Candida spp.

Decreased Use of Broad-Spectrum Antibiotics During the Coronavirus Disease 2019 Epidemic in South Korea

It is found that broad-spectrum antibiotic use was substantially reduced during the COVID-19 epidemic in South Korea, in part due to reduced ARTIs as a result of stringent public health interventions including social distancing measures.



COVID-19 pandemic and antimicrobial resistance: Another call to strengthen laboratory diagnostic capacity in Africa

How the COVID-19 pandemic could affect the already precarious AMR situation in Africa is discussed and ways to minimise the effects on public health are discussed.

The Novel Coronavirus COVID-19 Outbreak: Global Implications for Antimicrobial Resistance

  • A. Murray
  • Medicine
    Frontiers in Microbiology
  • 2020
This piece will highlight how managing the COVID-19 crisis could impact AMR in the clinic, beyond the clinic in the community, in the environment and in relation to public awareness.

PRO: The COVID-19 pandemic will result in increased antimicrobial resistance rates

It is argued that the COVID-19 pandemic will result in increased antimicrobial resistance (AMR), and the impact of CO VID-19 on AMR will vary between epicentres and non-epicentres, by geographic region, hospital to hospital within regions and within specific hospital units.

CON: COVID-19 will not result in increased antimicrobial resistance prevalence

It is shown why, overall, COVID-19 will not result in increased AMR prevalence, and how this should lead to a fall in resistance rates seen in many countries.

Tackling antimicrobial resistance in the COVID-19 pandemic

It is argued that antimicrobial stewardship activities should be integrated into the pandemic response across the broader health system through five measures: ensure the continuity of essential health services and regular supply of quality assured and affordable antimicrobials including antiretroviral and tuberculosis drugs, and vaccines.

COVID-19 and the potential long-term impact on antimicrobial resistance

Abstract The emergence of the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) has required an unprecedented response to control the spread of the infection and protect the most

COVID-19, superinfections and antimicrobial development: What can we expect?

  • C. ClancyM. Nguyen
  • Biology
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2020
Based on limited data from case series, it is reasonable to anticipate that an appreciable minority of patients with severe COVID-19 will develop superinfections, most commonly pneumonia due to nosocomial bacteria and Aspergillus.

Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance?

  • D. MonnetS. Harbarth
  • Medicine
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
  • 2020
AMR is another ongoing pandemic that often goes unnoticed by a majority of Europeans and is compared to a multitude of small fires that are much less visible than the single massive firestorm that is the COVID-19 pandemic.

COVID-19, antibiotics and One Health: a UK environmental risk assessment

The potential impact of antibiotic prescribing in COVID-19 patients in the UK is examined, providing environmental assessments relevant to designing optimal drug use and waste management systems in a One Health context and a risk assessment is carried out.

Access to effective antimicrobials: a worldwide challenge